4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-23-026581
Options or other derivatives
- Chief Executive Officer acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tak Paul Peter Chief Executive Officer | 2023-04-28 | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 | D | ||
Loading xslF345X04/doc4.xml…